NEPHROS, INC. Interest Expense, Lessee, Assets under Capital Lease
NEPHROS, INC. (NEPH) reported Interest Expense, Lessee, Assets under Capital Lease of $545 for the 12-month period ending 2015-12-31, per its 10-K filed 2016-03-30.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpenseLesseeAssetsUnderCapitalLease · last filed 2016-03-30
- NEPHROS, INC. interest expense, lessee, assets under capital lease for fiscal 2014 was 500.00 EUR.
EUR
| Period end | Interest Expense, Lessee, Assets under Capital Lease 12 month |
|---|---|
| 2014-12-31 | 500.00 EUR 10-K · filed 2015-04-15 |
USD
| Period end | Interest Expense, Lessee, Assets under Capital Lease 12 month |
|---|---|
| 2015-12-31 | $545.00 10-K · filed 2016-03-30 |
| 2014-12-31 | $600.00 10-K · filed 2015-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 |